• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

霍乱弧菌特征的变化:多重耐药性及非O1、非O139血清群的出现。

Changing characteristics of Vibrio cholerae: emergence of multidrug resistance and non-O1, non-O139 serogroups.

作者信息

Chandrasekhar M R, Krishna B V S, Patil Asha B

机构信息

Department of Microbiology, Raichur Institute of Medical Sciences, Raichur, India.

出版信息

Southeast Asian J Trop Med Public Health. 2008 Nov;39(6):1092-7.

PMID:19062701
Abstract

The serogroups and antimicrobial susceptibility patterns of V. cholerae isolated in Hubli, India during the years 2000 to 2004 were monitored. A total of 256 V. cholerae isolates were obtained during the study period, of which 129 (50.4%) belonged to serogroup O1 while the O139 and non-O1, non-O139 serogroups constituted 61 (23.8%) and 66 (25.8%) isolates, respectively. V. cholerae O1 Ogawa was the predominant isolate during the first 2 years of the study. However, this was replaced by V. cholerae non-O1, non-O139 serogroups in the following years. The V. cholerae, which was susceptible to most enteric antimicrobials in 2000, was found to be multidrug resistant in subsequent years, with the development of fluroquinolone resistance since 2002. Surveillance of the epidemiological and microbiological characteristics of V. cholerae provides useful information for managing cholera cases. The V. cholerae non-O1, non-O139 serogroups coupled with multiple antimicrobial resistance may form a group of emerging diarrheal pathogens in the tropics.

摘要

对2000年至2004年期间在印度胡布利分离出的霍乱弧菌血清群和抗菌药物敏感性模式进行了监测。在研究期间共获得256株霍乱弧菌分离株,其中129株(50.4%)属于O1血清群,而O139血清群以及非O1、非O139血清群分别占61株(23.8%)和66株(25.8%)。在研究的头两年,霍乱弧菌O1小川型是主要的分离株。然而,在随后几年中被非O1、非O139血清群的霍乱弧菌所取代。2000年对大多数肠道抗菌药物敏感的霍乱弧菌,在随后几年中被发现具有多重耐药性,自2002年以来出现了对氟喹诺酮的耐药性。对霍乱弧菌的流行病学和微生物学特征进行监测可为霍乱病例的管理提供有用信息。非O1、非O139血清群的霍乱弧菌加上多重抗菌药物耐药性可能在热带地区形成一组新出现的腹泻病原体。

相似文献

1
Changing characteristics of Vibrio cholerae: emergence of multidrug resistance and non-O1, non-O139 serogroups.霍乱弧菌特征的变化:多重耐药性及非O1、非O139血清群的出现。
Southeast Asian J Trop Med Public Health. 2008 Nov;39(6):1092-7.
2
Diversity of Vibrio cholerae strains isolated in Delhi, India, during 1992-2000.1992年至2000年期间在印度德里分离出的霍乱弧菌菌株的多样性。
J Health Popul Nutr. 2005 Mar;23(1):44-51.
3
Quinolone susceptibility of Vibrio cholerae O1 & O139 isolates from Vellore.来自韦洛尔的霍乱弧菌O1和O139分离株对喹诺酮类药物的敏感性
Indian J Med Res. 2002 Sep;116:96-8.
4
[Characterization of Vibrio cholerae non-O1 and non-O139 isolates associated with diarrhea].[与腹泻相关的霍乱弧菌非O1和非O139分离株的特征分析]
Rev Argent Microbiol. 2009 Jan-Mar;41(1):11-9.
5
Multiple antibiotic resistance profiles of Vibrio cholerae non-O1 and non-O139.霍乱弧菌非O1和非O139的多重抗生素耐药谱
Jpn J Infect Dis. 2009 May;62(3):230-2.
6
In vitro antimicrobial effect of cefazolin and cefotaxime combined with minocycline against Vibrio cholerae non-O1 non-O139.头孢唑林和头孢噻肟联合米诺环素对霍乱弧菌非O1非O139的体外抗菌作用
J Microbiol Immunol Infect. 2005 Dec;38(6):425-9.
7
Fluoroquinolone-resistant Vibrio cholerae isolated during a cholera outbreak in India.在印度霍乱疫情期间分离出的耐氟喹诺酮霍乱弧菌。
Trans R Soc Trop Med Hyg. 2006 Mar;100(3):224-6. doi: 10.1016/j.trstmh.2005.07.007. Epub 2005 Oct 24.
8
Prevalence and molecular characterization of Vibrio cholerae O1, non-O1 and non-O139 in tropical seafood in Cochin, India.印度科钦地区热带海产食品中霍乱弧菌 O1、非 O1 和非 O139 的流行情况及分子特征。
Foodborne Pathog Dis. 2013 Mar;10(3):278-83. doi: 10.1089/fpd.2012.1310.
9
Emergence of tetracycline-resistant Vibrio cholerae O1 serotype Inaba, in Kolkata, India.印度加尔各答出现对四环素耐药的霍乱弧菌O1型稻叶血清型菌株。
Jpn J Infect Dis. 2008 Mar;61(2):128-9.
10
Vibrio cholerae non-O1, non-O139 associated with seawater and plankton from coastal marine areas of the Caribbean Sea.加勒比海域沿海地区海水和浮游生物中与霍乱弧菌非 O1 群、非 O139 群相关的研究。
Int J Environ Health Res. 2009 Aug;19(4):279-89. doi: 10.1080/09603120802460368.

引用本文的文献

1
Resistance of to antibiotics that inhibit cell wall synthesis: A systematic review and meta-analysis.对抑制细胞壁合成抗生素的耐药性:一项系统评价和荟萃分析。
Front Pharmacol. 2023 Mar 20;14:1027277. doi: 10.3389/fphar.2023.1027277. eCollection 2023.
2
Non-serogroup O1/O139 agglutinable Vibrio cholerae: a phylogenetically and genealogically neglected yet emerging potential pathogen of clinical relevance.非 O1/O139 群可凝集霍乱弧菌:一种在系统发生和系统发育上被忽视但具有临床相关性的新兴潜在病原体。
Arch Microbiol. 2022 May 14;204(6):323. doi: 10.1007/s00203-022-02866-1.
3
New Developments in PCR-Based Diagnostics for Bacterial Pathogens Causing Gastrointestinal Infections-A Narrative Mini-Review on Challenges in the Tropics.
基于PCR的胃肠道感染细菌病原体诊断新进展——关于热带地区挑战的叙述性综述
Trop Med Infect Dis. 2021 Jun 2;6(2):96. doi: 10.3390/tropicalmed6020096.
4
Multifunctional-autoprocessing repeats-in-toxin (MARTX) Toxins of Vibrios.弧菌多功能自加工重复内毒素(MARTX)毒素。
Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.VE-0002-2014.
5
Analysis of Vibrio cholerae genome sequences reveals unique rtxA variants in environmental strains and an rtxA-null mutation in recent altered El Tor isolates.霍乱弧菌基因组序列分析揭示了环境菌株中独特的 rtxA 变体,以及近期变异埃尔托弧菌分离株中存在 rtxA 缺失突变。
mBio. 2013 Apr 16;4(2):e00624. doi: 10.1128/mBio.00624-12.
6
Antidiarrheal efficacy of a quinazolin CFTR inhibitor on human intestinal epithelial cell and in mouse model of cholera.抗腹泻喹唑啉 CFTR 抑制剂对人肠上皮细胞和霍乱小鼠模型的疗效。
Indian J Pharmacol. 2012 Sep-Oct;44(5):619-23. doi: 10.4103/0253-7613.100392.
7
Emerging trends in the etiology of enteric pathogens as evidenced from an active surveillance of hospitalized diarrhoeal patients in Kolkata, India.从印度加尔各答住院腹泻患者的主动监测中发现的肠病原体病因学的新趋势。
Gut Pathog. 2010 Jun 5;2(1):4. doi: 10.1186/1757-4749-2-4.
8
Targeting the replication initiator of the second Vibrio chromosome: towards generation of vibrionaceae-specific antimicrobial agents.靶向第二弧菌染色体的复制起始点:开发弧菌类特异性抗菌剂。
PLoS Pathog. 2009 Nov;5(11):e1000663. doi: 10.1371/journal.ppat.1000663. Epub 2009 Nov 20.